Medindia

X

Virginia, Maryland and Washington D.C. Health Insurers Seek to Reduce Pharmacy Costs

Friday, October 5, 2007 General News J E 4
Advertisement
NASHVILLE, Tenn., Sept. 26 HealthLeaders-InterStudy, theleading provider of managed care market intelligence, reports that healthinsurers in Virginia, Maryland and Washington D.C. (Mid-Atlantic region) arelooking to reduce pharma costs. According to the latest Mid-Atlantic HealthPlan Analysis, multiple strategies, including tiered pricing, no copays forgeneric drugs and robotic prescription fulfillment, are being employed to helpcontrol pharmacy expenses.

According to the report, average weighted pharmacy expenses for Mid-Atlantic plans rose from $26 to $33 per member, per month from 2004 to 2006.Most large commercial insurers saw their pharmacy costs increase in the Mid-Atlantic anywhere from 8 percent to 14 percent.

Health plans are continuing to experiment with innovative ways to controlmembers' drug costs by focusing on copay waivers, strategies and technology.Aetna introduced "Save a Copay," a member incentive that waives the copay forcholesterol-lowering generic drug for six months. CIGNA has its own in-housemail-order operation, CIGNATel-Drug, which is tied to its drug cost comparisontool. By going to myCIGNA.com, members can compare costs of their medicationsat nearby pharmacies with their personal benefits factored in. KaiserPermanente offers members the convenience of online ordering and uses roboticsat their central fill, which allows them to process prescriptions at highvolume.

"Health plans have approached the problem of high drug costs with creativestrategies and innovative automation, but ultimately the solution to highcosts in healthcare is a strong move toward wellness and prevention," said JanShuxteau, market analyst for HealthLeaders-InterStudy. "This is good news forconsumers and health plans, especially in areas such as the Mid-Atlantic wherepharmacy costs are still rising and the outlook for savings is good."

About Health Plan Analysis

Health Plan Analysis identifies key health plan trends, allowinghealthcare businesses to create comprehensive strategic plans and salesstrategies at state and local levels.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy is the authoritative source for managed care dataand analysis. For more information, please visitwww.HealthLeaders-InterStudy.com.

All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Elizabeth Marshall Decision Resources 781-296-2563 emarshall@dresources.com

SOURCE HealthLeaders-InterStudy
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Genzyme and Bayer Schering Pharma AG, Germany Anno...
S
Emergence of Cancer Vaccines Will Be the Key Facto...